Weight Gain After Fecal Microbiota Transplantation
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Fecal microbiota transplantation (FMT) is a promising treatment for recurrent Clostridium difficile infection. We report a case of a woman successfully treated with FMT who developed new-onset obesity after receiving stool from a healthy but overweight donor. This case may stimulate further studies on the mechanisms of the nutritional-neural-microbiota axis and reports of outcomes in patients who have used nonideal donors for FMT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to modulating immune responses, the composition of commensal microbiota has been linked to chronic diseases, with a theoretical risk of transferring obesity from donor to recipient (30).”
From The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies (2018) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788 · cited 1×
“The hypothesis of FMT triggering or contributing to obesity is supported by animal models demonstrating that an obese microbiota can be transmitted [2].”
Youngster, I., Sauk, J., Pindar, C., Wilson, R. G., Kaplan, J. L., Smith, M. B., Alm, E. J., Gevers, D., Russell, G. H., & Hohmann, E. L. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu135 · Cited by 467 · cited 10×
“She improved and did not suffer a further CDI recurrence after FMT.”
BackgroundInfluentialReview article: associations between Helicobacter pylori and obesity - an ecological study
Lender, N., Talley, N. J., Enck, P., Haag, S., Zipfel, S., Morrison, M., & Holtmann, G. J. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12790 · Cited by 108
Cited by
Items 301–400 of 445
Malnick, S. D. H., & Michael, S. O. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45090455 · Cited by 7
Kenna, T., Hanson, A., Costello, M., & Brown, M. A. (2016) · Current Rheumatology Reports · doi:10.1007/s11926-016-0612-x · Cited by 7
Swiss expert opinion: current approaches in faecal microbiota transplantation in daily practice
Rossier, L., Matter, C., Burri, E., Galpérine, T., Hruz, P. L., Juillerat, P., Schoepfer, A. M., Vavricka, S. R., Zahnd, N., Décosterd, N., et al. (2023) · Swiss Medical Weekly · doi:10.57187/smw.2023.40100 · Cited by 6
Impact of fecal microbiota transplantation in dogs
Cantas, L., Goll, R., Fenton, C. G., Paulssen, R. H., & Sørum, H. R. (2025) · Frontiers in Veterinary Science · doi:10.3389/fvets.2025.1505226 · Cited by 6
Gîlcă-Blanariu, G.-E., Ștefănescu, G., Gîrleanu, I., Iqbal, T. H., Segal, J. P., Mullish, B. H., Quraishi, M. N., Keller, J. J., Molnár, T., Mégraud, F., et al. (2021) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-3297 · Cited by 6
Bocchetti, M., Ferraro, M. G., Melisi, F., Grisolia, P., Scrima, M., Cossu, A. M., & Yau, T. O. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i22.3385 · Cited by 6
Desarrollo de la Microbiota Gastrointestinal en Lactantes y Su Rol en Salud y Enfermedad
Honeyman, C. A. S., León, M. A., & Diez, P. H. (2016) · ARS MEDICA Revista de Ciencias Médicas · doi:10.11565/arsmed.v41i1.53 · Cited by 6
Clinical care is evolving: The microbiome for advanced practice nurses
Lockwood, M. B., & Green, S. J. (2020) · Journal of the American Association of Nurse Practitioners · doi:10.1097/jxx.0000000000000379 · Cited by 6
Segal, J. P., Abbasi, F., Kanagasundaram, C., & Hart, A. L. (2018) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s159609 · Cited by 6
Stadlbauer, V. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13020220 · Cited by 6
Kulecka, M., Jaworski, P., Żeber‐Lubecka, N., Bałabas, A., Piątkowska, M., Czarnowski, P., Frączek, B., Tarnowski, W., Mikuła, M., & Ostrowski, J. (2025) · Nutrients · doi:10.3390/nu17142320 · Cited by 5
Advances and challenges in microbiome transplantation
Sen, P., Kaulmann, D., Youngster, I., Abdeen, S. K., & Elinav, E. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.06.006 · Cited by 5
THE ROLE OF GUT MICROBIOTA IN THE DEVELOPMENT OF OBESITY
Воловникова, В. А., Kotrova, A., Ivanova, K. A., Ермоленко, Е. И., & Shishkin, A. N. (2019) · Juvenis scientia · doi:10.32415/jscientia.2019.06.01 · Cited by 5
Age-Matching in Pediatric Fecal Matter Transplants
MacLellan, A. D., Finlay, B. B., & Appel‐Cresswell, S. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.603423 · Cited by 5
Brumfield, K. D., Cox, P., Geyer, J. D., & Goepp, J. G. (2023) · Pathogens · doi:10.3390/pathogens12020238 · Cited by 5
Akamatsu, Y., Morishita, S., Chikumi, H., Okamoto, R., Okada, K., Kitaura, T., Miyake, N., Yamaguchi, K., Nakamoto, M., Shimohiro, H., et al. (2018) · The Journal of Medical Investigation · doi:10.2152/jmi.65.131 · Cited by 5
Genome Editing of Food-Grade Lactobacilli To Develop Therapeutic Probiotics
van Pijkeren, J., & Barrangou, R. (2018) · ASM Press eBooks · doi:10.1128/9781555819705.ch17 · Cited by 5
Samulenaite, S., Parkitna, J. M. R., Baltriukienė, D., Martín‐García, E., Maldonado, R. J., & Burokas, A. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2647535 · Cited by 4
Starvation as a weapon against cancer
Dubnik, S., & Skopec, R. (2017) · International Journal of Cancer Epidemiology and Research · doi:10.25141/2572-7664-2017-1.0001 · Cited by 4
Personalised medicine based on host genetics and microbiota applied to colorectal cancer
González, A., Badiola, I., Fullaondo, A., Rodríguez, J., & Odriozola, A. (2024) · Advances in genetics · doi:10.1016/bs.adgen.2024.08.004 · Cited by 4
Fecal Microbiota Transplantation as Therapy for Inflammatory Bowel Disease
Schneider, A., & Maric, L. V. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811388-2.00028-2 · Cited by 4
Gut microbes as a therapeutic armory
Bhardwaj, N., & Geva‐Zatorsky, N. (2018) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2019.08.007 · Cited by 4
Fecal Microbiome Transplantation: An Offhand Recipe for Microbiome Therapeutics
Radhakrishanan, A., Kakkar, P., Tandon, C., & Srivastav, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00001-2 · Cited by 4
The Gut Microbiota and Host Metabolism
Schroeder, B. O. (2022) · Progress in inflammation research · doi:10.1007/978-3-030-91051-8_5 · Cited by 4
Faecal microbiota transplantation (FMT): classical bedside-to-bench clinical research
Murphy, C. L., Zulquernain, S., & Shanahan, F. (2019) · QJM · doi:10.1093/qjmed/hcz181 · Cited by 4
Implications of microbe-mediated crosstalk in the gut: Impact on metabolic diseases
Beg, R., Gonzalez, K., & Martinez, K. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159180 · Cited by 4
Vehreschild, M. J. G. T., & Cornely, O. A. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv768 · Cited by 4
Hohmann, E. L. (2016) · Annals of Internal Medicine · doi:10.7326/m16-1784 · Cited by 4
On the Stability Landscape of the Human Gut Microbiome: Implications for Microbiome-based TherapiesPreprint
Gibson, T. E., Carey, V. J., Bashan, A., Hohmann, E. L., Weiss, S. T., & Liu, Y. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/176941 · Cited by 4
The Gut Microbiota: An Essential Component in Understanding Pediatric Obesity: A Narrative Review
Lupu, V. V., Nedelcu, A. H., Balas, R. B., Anton, C., Tarnita, I., Azoicai, A. N., Forna, L., Munteanu, D., Anton, S. C., Shawais, S. K., et al. (2026) · Nutrients · doi:10.3390/nu18060952 · Cited by 4
Biedermann, L., Rogler, G., & Zeitz, J. (2017) · Schweizerische Zeitschrift für Ganzheitsmedizin / Swiss Journal of Integrative Medicine · doi:10.1159/000475586 · Cited by 3
Using bugs as drugs: Microbial ecosystem therapeutics
Allen‐Vercoe, E., & Petrof, E. (2015) · Canada Communicable Disease Report · doi:10.14745/ccdr.v41is5a01 · Cited by 3
Sehgal, K., Berry, P., Cho, J. M., Saffouri, G. B., Dierkhising, R., Battaglioli, E. J., Kashyap, P., Pardi, D. S., & Khanna, S. (2025) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848251321121 · Cited by 3
Fekal mikrobiyota transplantasyonu ve hastalıklar üzerine etkileri
Akyüz, E. Y., & Sürücü, Y. (2020) · Sağlık akademisyenleri dergisi/Sağlık akademisyenler dergisi · Cited by 3
MAFLD under the lens: the role of gut microbiota
Sousa, P., & Machado, M. V. (2022) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2022.15 · Cited by 3
Gastroenvironmental distress: metaphorical antecedents of the gut microbiome
Ahuja, N. K., & Ahuja, A. (2016) · Medical Humanities · doi:10.1136/medhum-2015-010784 · Cited by 3
Dehestani, B., & le Roux, C. W. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8070942 · Cited by 3
Effect of Probiotics in the Mitigation of Clostridium difficile Associated Disease
Adekunle, O. (2015) · Digital Archive @ GSU · doi:10.57709/7032560 · Cited by 3
Jäger, E., Peeva, V., Gnad, T., Haange, S., Rolle-Kampczyk, U. E., Stäubert, C., Krumbholz, P., Heiker, J. T., Gebhardt, C., Krügel, U., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020917 · Cited by 2
The Therapeutic Potential of the “Yin-Yang” Garden in Our Gut
Srikumar, S., & Fanning, S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.80881 · Cited by 2
Dinda, B., & Saha, S. (2022) · Springer eBooks · doi:10.1007/978-3-030-92196-5_1 · Cited by 2
Human virome in health and disease
Xue, J., Mirzaei, M. K., Costa, R., Smith, S., Tiamani, K., Ma, T., & Deng, L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-818619-0.00128-3 · Cited by 2
Clostridium difficile Infection: Current and Emerging Therapeutics
Jarrad, A. M., Blaskovich, M. A. T., Lyras, D., & Cooper, M. A. (2015) · Current treatment options in infectious diseases/Current treatment options in infectious disease · doi:10.1007/s40506-015-0062-4 · Cited by 2
Fecal Microbiota Transplants: Current Knowledge and Future Directions
Chis, R., Sheth, P. M., & Petrof, E. O. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7534-1_11 · Cited by 2
The role of gut microbiota in cardiovascular diseases
Aksoyalp, Z. Ş., & Nacıtarhan, C. (2018) · Turkish Bulletin of Hygiene and Experimental Biology · doi:10.5505/turkhijyen.2018.32068 · Cited by 2
Introduction to Microbes and Infection in the Modern World
Doloff, J. C. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788012638-00038 · Cited by 2
Is a Fecal Microbiota Transplant Useful for Treating Inflammatory Bowel Disease?
Suceveanu, A., Andrada, D., Musat, M., Voinea, C., Voinea, F., Parepa, I. R., Stoian, A. P., Mazilu, L., & Suceveanu, A. P. (2021) · Biochemistry · doi:10.5772/intechopen.91444 · Cited by 2
Pathogenetic substantiation of approaches to the treatment of non-alcoholic fatty liver disease.
Bogomolov, P., Мациевич, М. В., Kokina, K. Y., Mayorov, A. Y., & Mishina, E. Е. (2018) · Clinical Medicine (Russian Journal) · doi:10.18821/0023-2149-2017-95-12-1077-1085 · Cited by 2
Desselberge, U. (2020) · Journal of Cellular Immunology · doi:10.33696/immunology.2.058 · Cited by 2
Joachim, A., Schwerd, T., Hoelz, H., Sokollik, C., Konrad, L., Jordan, A., Lanzersdorfer, R., Choudhury, A. R., Hünseler, C., & Adam, R. (2022) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1801-0284 · Cited by 2
Schmidt, F., & Siegmund, B. (2018) · Springer eBooks · doi:10.1007/978-3-319-90545-7_20 · Cited by 2
Estimating the risks of faecal transplants
Patel, K., & Spector, T. D. (2015) · Journal of Hospital Infection · doi:10.1016/j.jhin.2015.11.017 · Cited by 2
La microbiota humana como estrategia farmacológica en el entorno regulatorio europeo.
Gosálbez Cisneros-Miret, L. J. (2017) · RIUCAM · Cited by 2
McCormack, U. (2017) · SETU Waterford Libraries - Open Access Repository · Cited by 2
Hoffman, R. L. (2020) · Springer eBooks · doi:10.1007/978-3-030-30730-1_24 · Cited by 1
Targeting the Gut Microbiota for Health
Ishiguro, E. E., Haskey, N., & Campbell, K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91387-4.00005-3 · Cited by 1
Ji, Y., Zhao, L., Wang, L., Wang, A., Zhang, C., Xie, Y., & Luo, X. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1840517 · Cited by 1
Adiga, U., Vasishta, S., Adiga, S., & Augustine, A. A. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11124-5 · Cited by 1
Fäkale Mikrobiotatransplantation (FMT): Gesicherte Therapieindikationen und Zukunftsperspektiven
Lübbert, C. (2016) · Der Diabetologe · doi:10.1007/s11428-016-0125-2 · Cited by 1
The Gut Microbiota and Obesity in Humans
Efthymakis, K., Leonello, R., Pace, F., & Neri, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-30361-1_3 · Cited by 1
Die Bedeutung des Mikrobioms für die Adipositas: Machen Darmbakterien dick?
Bertram, F., Menge, D., & Andresen, V. (2017) · Der Gynäkologe · doi:10.1007/s00129-016-4022-y · Cited by 1
A study into the human gut microbiome
Chaparro, C. (2017) · Cardinal Scholar (Ball State University) · Cited by 1
Die Bedeutung des Mikrobioms für die Adipositas: Machen Darmbakterien dick?
Bertram, F., Menge, D., & Andresen, V. (2017) · Der Diabetologe · doi:10.1007/s11428-017-0229-3 · Cited by 1
Brennan, L., Al, K. F., Bjazevic, J., RAZVI, H. A., & Burton, J. P. (2019) · Springer eBooks · doi:10.1007/978-3-030-17542-9_8 · Cited by 1
Examining the Relationship between Urinary Pathogens, Antibiotic Exposure and Urolithiasis
Bjazevic, J. (2019) · Scholarship@Western (Western University) · Cited by 1
Faintuch, J., & Faintuch, J. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815249-2.00046-4 · Cited by 1
Faecal Microbiota Transplantation for Clostridium Difficile - a local perspective.
Diamond, C., & McNeilly, T. (2017) · PubMed Central · Cited by 1
Fecale microbiota transplantatie, meer dan een behandeling voor Clostridium difficile?
Nieuwdorp, M. (2020) · Bijblijven · doi:10.1007/s12414-020-0117-4 · Cited by 1
Protection from Staphylococcus Aureus Bloodstream Infection by Probiotic Exopolysaccharide
Paik, W. (2019) · Loyola eCommons (Loyola University of Chicago) · Cited by 1
O TRANSPLANTE FECAL E SUA POSSÍVEL APLICAÇÃO NO TRATAMENTO DA OBESIDADE: UMA REVISÃO DE LITERATURA
Dalcin, C. A. M., Aguera, R. G., & Ecker, A. B. D. S. (2019) · Revista Uningá · doi:10.46311/2318-0579.56.euj2811 · Cited by 1
Update on fecal microbial transplantation for the treatment of inflammatory bowel disease
Llirós, M., Lluansí, A., Peries, L., Bahí, A., Ramió‐Pujol, S., & Aldeguer, X. (2021) · Journal of IMIDs · doi:10.24875/jimids.m21000008 · Cited by 1
Microbiota, Microbiome, and Retinal Diseases
Singh, N., & Haider, N. B. (2022) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000418 · Cited by 1
Control of Clostridium difficile Infection by Defined Microbial Communities
Collins, J., & Auchtung, J. M. (2018) · ASM Press eBooks · doi:10.1128/9781555819705.ch11 · Cited by 1
Pediatric Obesity and Non-Hepatobiliary Gastrointestinal Disorders: A Comprehensive Review
Sen, S., & Misra, S. (2024) · Gastroenterology Hepatology & Digestive Disorders · doi:10.33425/2639-9334.1086 · Cited by 1
Quantitative modeling for microbial ecology and clinical trials
Olesen, S. W. (2016) · DSpace@MIT (Massachusetts Institute of Technology) · Cited by 1
Roberts, D. (2017) · ORCA Online Research @Cardiff (Cardiff University) · Cited by 1
Microorganismos como medicamentos, ¿Podemos gestionar la microbiota?
Blanco, P. M. (2020) · UCrea (University of Cantabria) · Cited by 1
Huang, F. (2021) · Mspace (University of Manitoba) · Cited by 1
Hypothetical Epigenetic Fingerprint in Nutritional-Neural-microbiota Connection
(2015) · Stem Cell Epigenetics · doi:10.14800/sce.863
GUT in FOCUS Symposium NOBEL FORUM, Karolinska Institutet
(2015) · Microbial Ecology in Health and Disease · doi:10.3402/mehd.v26.28480
Kirupananthan, A. (2015) · Gastrointestinal Nursing · doi:10.12968/gasn.2015.13.10.48
It's a small world: Biogeography and invasion in the mouse intestine
Lark, E. (2015) · ScholarWorks at University of Montana
Mikrobiom, Adipositas und Energiestoffwechsel
Chakaroun, R., & Blüher, M. (2016) · Der Diabetologe · doi:10.1007/s11428-016-0123-4
Advances in Fecal Microbiota TransplantationPreprint
Gollamudi, S. (2016) · doi:10.15200/winn.148321.15013
The Intestinal Microbiome, the Immune System and Spondyloarthropathy
Costello, M., & Brown, M. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-42252-7_8
The gut microbiota and childhood weight development
Mbakwa, C. A. (2016) · Research Publications (Maastricht University) · doi:10.26481/dis.20161006cm
Energy Balance: Through the Looking Glass
Brilla, L. R. (2016) · Journal of Sports Medicine & Doping Studies · doi:10.4172/2161-0673.1000e149
A ROLE FOR BACTERIAL-DERIVED PROTEASES AND PROTEASE INHIBITORS IN FOOD SENSITIVITY.
McCarville, J. L. (2017) · MacSphere (McMaster University) · doi:10.71548/24182
THE ROLE OF THE INTESTINAL MICROBIOTA IN THE MODULATION OF FOOD INTAKE AND BODY WEIGHTPreprint
Dalby, M. J. (2017) · Thesis Commons (OSF Preprints) · doi:10.31237/osf.io/rqz2p
Mechanistic And Inhibitory Analysis Of Clostridium Difficile Associated Diseases
Jackman, B. M. (2016) · Human Biology
The Function and Biogenesis of the Clostridium difficile S-layer
Kirk, J. A. (2017) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Axt-Gadermann, M., & Lorenz, V. (2018) · Ernährung & Medizin · doi:10.1055/s-0043-124127
Therapeutic Manipulation of Gut Microbiota
Ishiguro, E. E., Haskey, N., & Campbell, K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-810541-2.00007-5
Recours à des bactéries en tant que médicaments : traitements de l’écosystème microbien
Allen‐Vercoe, E., & Petrof, E. (2015) · Relevé des maladies transmissibles au Canada · doi:10.14745/ccdr.v41is5a01f
The acquisition of clostridium difficile-associated disease: the role of nutritional care
Peters, V. A. (2018) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Steinberg, R. (2016) · The Science Journal of the Lander College of Arts and Sciences
Microbial modulation of metabolic diseases
Molinaro, A. (2018) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Novel Insights in Ankylosing Spondylitis Biology: Mouse and Human Studies
Lin, A. (2018) · TSpace (University of Toronto)
Gut microbes in the prevention and onset of metabolic disorders
Keskitalo, A. (2019) · UTUPub (University of Turku)
Microbiota: Novel Gateway Towards Personalised Medicine
Žučko, J., Starčević, A., Diminić, J., & Oros, D. (2019) · Europeanization and globalization · doi:10.1007/978-3-030-16465-2_9
Metadata
- Authors
- Alang, N., & Kelly, C. R.
- Affiliations
- Newport Hospital (US)
- Brown University (US)
- Corresponding author
- Alang, Neha
- ORCID
- Kelly, Colleen R.
- Venue
- Open Forum Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-01-01
- Volume
- 2
- Issue
- 1
- Pages
- ofv004-ofv004
- ISSN
- 2328-8957 (ISSN-L)
- PMC
- PMC4438885
- OpenAlex
- W2121441667
- Cited by
- 403
- References
- 3
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 16 · 2023: 25 · 2022: 33 · 2021: 33 · 2020: 46 · 2019: 40 · 2018: 52 · 2017: 52 · 2016: 57 · 2015: 27
- FWCI
- 48.80
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Open Forum Infectious Diseases (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- fecal microbiota transplantation, weight gain, donor obesity, Clostridium difficile infection, recurrent infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.